| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000045655 |
| Receipt No. | R000052119 |
| Scientific Title | Evaluation study of visceral fat and inflammatory markers by intake of banana |
| Date of disclosure of the study information | 2021/10/04 |
| Last modified on | 2021/12/17 (Ver. 3) |
| Basic information | ||
| Public title | Evaluation study of visceral fat and inflammatory markers by intake of banana | |
| Acronym | Evaluation study of visceral fat and inflammatory markers by intake of banana | |
| Scientific Title | Evaluation study of visceral fat and inflammatory markers by intake of banana | |
| Scientific Title:Acronym | Evaluation study of visceral fat and inflammatory markers by intake of banana | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Investigate the effects of banana intake for one month on visceral fat area and inflammatory markers in blood in a randomized parallel group comparison study for subjects with BMI of 24 or higher. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Changes in visceral fat area 4 weeks after the start of ingestion |
| Key secondary outcomes | Fasting blood index (total protein, albumin, total cholesterol, LDL cholesterol, HDL cholesterol, neutral fat, urea nitrogen, creatinine, uric acid, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), serum insulin, glycoalbumin, sodium, potassium, chlorine, calcium, magnesium, inorganic phosphorus, serum iron, blood count, high-sensitivity CRP, interleukin 6, ferritin)
Body composition (body weight, BMI, lean body mass) Blood pressure (systolic blood pressure, diastolic blood pressure) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -investigator(s) and assessor(s) are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingest 2 bananas (about 120g of edible portion) every day for 4 weeks by 20:00 at non-specified time.
There are no restrictions on the usual meal time. |
|
| Interventions/Control_2 | Do not ingest bananas for 4 weeks.
There are no restrictions on the usual meal time. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Healthy Japanese who are 21 years old or more and under 44 years old at the time of obtaining consent 3.Persons who have BMI of 24 or more at the time of obtaining consent |
|||
| Key exclusion criteria | 1.Persons who are currently suffering from some kind of disease and are judged by the investigator to need treatment
2.Persons with severe anemia 3.Pregnant, lactating, pregnant 4.Persons who may cause allergic symptoms to the ingredients contained in the test food 5.Persons with alcoholism or other mental disorders 6.Persons who have a smoking habit, those who have quit smoking for less than 10 year 7. Persons who may change their lifestyle during the examination period (night shift, long trip, etc.) 8.Persons who may develop seasonal allergic symptoms such as pollinosis during the test period 9.Persons who plan to take new health foods and supplement foods during the examination period 10.Persons who have received hormone replacement therapy within the past 6 months 11.Persons who have been treated with hospitalization within the past 6 months 12.Persons who participate in other clinical studies or participated in the last 3 months or plan to participate in other clinical studies. 13.Persons who are judged by the investigator to be inappropriate for this study. |
|||
| Target sample size | 36 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Akasaka Family Clinic | ||||||
| Division name | Clinic Director | ||||||
| Zip code | 107-0052 | ||||||
| Address | Akasaka Plaza Bldg., 3rd Floor, Akasaka 2-15-15, Minato-ku, Tokyo | ||||||
| TEL | 03-5562-8825 | ||||||
| info@afc.tokyo | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Healthcare Systems Co., Ltd. | ||||||
| Division name | Research and Development Department | ||||||
| Zip code | 105-0004 | ||||||
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
| TEL | 03-6809-2722 | ||||||
| Homepage URL | |||||||
| asahina.yuki@hc-sys.jp | |||||||
| Sponsor | |
| Institute | Akasaka Family Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Banana Importers Association. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Ethics Committee of Healthcare Systems Co., Ltd. |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| Tel | 03-6809-2722 |
| soumu@hc-sys.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052119 |